研究报告 |
|
|
|
|
脑血管内皮细胞敲除Prmt5导致脑血管损伤及星形胶质细胞活化* |
宁慧敏1,2,张一哲2,韩钰莹2,张翀2,宋晓朋2,梁爽2,杨晓1,2,**(),王俊2,**() |
1 青岛大学基础医学院 青岛 266071 2 军事科学院军事医学研究院生命组学研究所 蛋白质组学国家重点实验室 北京 102206 |
|
Deletion of Prmt5 in Cerebral Endothelial Cells Leads to Cerebrovascular Disease and Astrocyte Activation |
NING Hui-min1,2,ZHANG Yi-zhe2,HAN Yu-ying2,ZHANG Chong2,SONG Xiao-peng2,LIANG Shuang2,YANG Xiao1,2,**(),WANG Jun2,**() |
1 School of Basic Medicine, Qingdao University, Qingdao 266071, China 2 State Key Laboratory of Proteomics, Beijing National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China |
引用本文:
宁慧敏, 张一哲, 韩钰莹, 张翀, 宋晓朋, 梁爽, 杨晓, 王俊. 脑血管内皮细胞敲除Prmt5导致脑血管损伤及星形胶质细胞活化*[J]. 中国生物工程杂志, 2022, 42(4): 1-8.
NING Hui-min, ZHANGYi-zhe, HAN Yu-ying, ZHANG Chong, SONG Xiao-peng, LIANG Shuang, YANG Xiao, WANG Jun . Deletion of Prmt5 in Cerebral Endothelial Cells Leads to Cerebrovascular Disease and Astrocyte Activation. China Biotechnology, 2022, 42(4): 1-8.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2112026
或
https://manu60.magtech.com.cn/biotech/CN/Y2022/V42/I4/1
|
[1] |
Sweeney M D, Zhao Z, Montagne A, et al. Blood-brain barrier: from physiology to disease and back. Physiological Reviews, 2019, 99(1): 21-78.
doi: 10.1152/physrev.00050.2017
|
[2] |
Bernstein D L, Gajghate S, Reichenbach N L, et al. Let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model. Brain, Behavior, and Immunity, 2020, 87: 543-555.
doi: S0889-1591(19)31341-8
pmid: 32017988
|
[3] |
Zhao Z, Nelson A R, Betsholtz C, et al. Establishment and dysfunction of the blood-brain barrier. Cell, 2015, 163(5): 1064-1078.
doi: 10.1016/j.cell.2015.10.067
|
[4] |
Blanc R S, Richard S. Arginine methylation: the coming of age. Molecular Cell, 2017, 65(1): 8-24.
doi: 10.1016/j.molcel.2016.11.003
|
[5] |
Hamard P J, Santiago G E, Liu F, et al. PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes. Cell Reports, 2018, 24(10): 2643-2657.
doi: 10.1016/j.celrep.2018.08.002
|
[6] |
Webb L M, Sengupta S, Edell C, et al. Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity. The Journal of Clinical Investigation, 2020, 130(4): 1683-1698.
doi: 10.1172/JCI131254
|
[7] |
Zhang T, Günther S, Looso M, et al. Prmt5 is a regulator of muscle stem cell expansion in adult mice. Nature Communications, 2015, 6: 7140.
doi: 10.1038/ncomms8140
pmid: 26028225
|
[8] |
Liu M, Yao B, Gui T, et al. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression. Theranostics, 2020, 10(10): 4437-4452.
doi: 10.7150/thno.42047
|
[9] |
Meng F W, Shi L, Cheng X, et al. Surfactant protein A promoter directs the expression of Cre recombinase in brain microvascular endothelial cells of transgenic mice. Matrix Biology, 2007, 26(1): 54-57.
doi: 10.1016/j.matbio.2006.09.003
|
[10] |
Li Z H, Xu J P, Song Y, et al. PRMT5 prevents dilated cardiomyopathy via suppression of protein O-GlcNAcylation. Circulation Research, 2021, 129(9): 857-871.
doi: 10.1161/CIRCRESAHA.121.319456
|
[11] |
Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease. Neurobiology of Aging, 2001, 22(6): 837-842.
pmid: 11754990
|
[12] |
Grammas P, Samany P G, Thirumangalakudi L. Thrombin and inflammatory proteins are elevated in Alzheimer’s disease microvessels: implications for disease pathogenesis. Journal of Alzheimer’s Disease: JAD, 2006, 9(1): 51-58.
|
[13] |
Liddelow S A, Guttenplan K A, Clarke L E, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 2017, 541(7638): 481-487.
doi: 10.1038/nature21029
|
[14] |
King A, Szekely B, Calapkulu E, et al. The increased densities, but different distributions, of both C3 and S100A10 immunopositive astrocyte-like cells in Alzheimer’s disease brains suggest possible roles for both A1 and A2 astrocytes in the disease pathogenesis. Brain Sciences, 2020, 10(8): 503.
doi: 10.3390/brainsci10080503
|
[15] |
Grammas P, Martinez J, Sanchez A, et al. A new paradigm for the treatment of Alzheimer’s disease: targeting vascular activation. Journal of Alzheimer’s Disease: JAD, 2014, 40(3): 619-630.
|
[16] |
Zamanian J L, Xu L, Foo L C, et al. Genomic analysis of reactive astrogliosis. The Journal of Neuroscience, 2012, 32(18): 6391-6410.
doi: 10.1523/JNEUROSCI.6221-11.2012
|
[17] |
Stogsdill J A, Ramirez J, Liu D, et al. Astrocytic neuroligins control astrocyte morphogenesis and synaptogenesis. Nature, 2017, 551(7679): 192-197.
doi: 10.1038/nature24638
|
[18] |
Jaudon F, Chiacchiaretta M, Albini M, et al. Kidins220/arms controls astrocyte calcium signaling and neuron-astrocyte communication. Cell Death and Differentiation, 2020, 27(5): 1505-1519.
doi: 10.1038/s41418-019-0431-5
pmid: 31624352
|
[19] |
Sofroniew M V, Vinters H V. Astrocytes: biology and pathology. Acta Neuropathologica, 2010, 119(1): 7-35.
doi: 10.1007/s00401-009-0619-8
pmid: 20012068
|
[20] |
Yang J H, Vitery M D C, Chen J N, et al. Glutamate-releasing SWELL1 channel in astrocytes modulates synaptic transmission and promotes brain damage in stroke. Neuron, 2019, 102(4): 813-827.e6.
doi: 10.1016/j.neuron.2019.03.029
|
[21] |
Díaz-García C M, Mongeon R, Lahmann C, et al. Neuronal stimulation triggers neuronal glycolysis and not lactate uptake. Cell Metabolism, 2017, 26(2): 361-374.e4.
doi: S1550-4131(17)30421-7
pmid: 28768175
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|